Chest CT opportunistic biomarkers for phenotyping high-risk COVID-19 patients: a retrospective multicentre study.
COVID-19
Computed tomography
Coronary artery disease
Fatty liver
Sarcopenia
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
24
09
2022
accepted:
21
03
2023
revised:
11
03
2023
medline:
27
10
2023
pubmed:
11
5
2023
entrez:
11
5
2023
Statut:
ppublish
Résumé
To assess the value of opportunistic biomarkers derived from chest CT performed at hospital admission of COVID-19 patients for the phenotypization of high-risk patients. In this multicentre retrospective study, 1845 consecutive COVID-19 patients with chest CT performed within 72 h from hospital admission were analysed. Clinical and outcome data were collected by each center 30 and 80 days after hospital admission. Patients with unknown outcomes were excluded. Chest CT was analysed in a single core lab and behind pneumonia CT scores were extracted opportunistic data about atherosclerotic profile (calcium score according to Agatston method), liver steatosis (≤ 40 HU), myosteatosis (paraspinal muscle F < 31.3 HU, M < 37.5 HU), and osteoporosis (D12 bone attenuation < 134 HU). Differences according to treatment and outcome were assessed with ANOVA. Prediction models were obtained using multivariate binary logistic regression and their AUCs were compared with the DeLong test. The final cohort included 1669 patients (age 67.5 [58.5-77.4] yo) mainly men 1105/1669, 66.2%) and with reduced oxygen saturation (92% [88-95%]). Pneumonia severity, high Agatston score, myosteatosis, liver steatosis, and osteoporosis derived from CT were more prevalent in patients with more aggressive treatment, access to ICU, and in-hospital death (always p < 0.05). A multivariable model including clinical and CT variables improved the capability to predict non-critical pneumonia compared to a model including only clinical variables (AUC 0.801 vs 0.789; p = 0.0198) to predict patient death (AUC 0.815 vs 0.800; p = 0.001). Opportunistic biomarkers derived from chest CT can improve the characterization of COVID-19 high-risk patients. In COVID-19 patients, opportunistic biomarkers of cardiometabolic risk extracted from chest CT improve patient risk stratification. • In COVID-19 patients, several information about patient comorbidities can be quantitatively extracted from chest CT, resulting associated with the severity of oxygen treatment, access to ICU, and death. • A prediction model based on multiparametric opportunistic biomarkers derived from chest CT resulted superior to a model including only clinical variables in a large cohort of 1669 patients suffering from SARS- CoV2 infection. • Opportunistic biomarkers of cardiometabolic comorbidities derived from chest CT may improve COVID-19 patients' risk stratification also in absence of detailed clinical data and laboratory tests identifying subclinical and previously unknown conditions.
Identifiants
pubmed: 37166497
doi: 10.1007/s00330-023-09702-0
pii: 10.1007/s00330-023-09702-0
pmc: PMC10173240
doi:
Substances chimiques
Biomarkers
0
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7756-7768Informations de copyright
© 2023. The Author(s).
Références
Palmisano A, Scotti GM, Ippolito D et al (2021) Chest CT in the emergency department for suspected COVID-19 pneumonia. Radiol Med 126:498–502. https://doi.org/10.1007/S11547-020-01302-Y
doi: 10.1007/S11547-020-01302-Y
pubmed: 33165767
Giannitto C, Sposta FM, Repici A et al (2020) Chest CT in patients with a moderate or high pretest probability of COVID-19 and negative swab. Radiol Med 125:1260–1270. https://doi.org/10.1007/S11547-020-01269-W
doi: 10.1007/S11547-020-01269-W
pubmed: 32862406
pmcid: 7456362
Loffi M, Regazzoni V, Toselli M, et al (2021) Incidence and characterization of acute pulmonary embolism in patients with SARS-CoV-2 pneumonia: a multicenter Italian experience. PLoS One 16. https://doi.org/10.1371/JOURNAL.PONE.0245565
Esposito A, Palmisano A, Cao R et al (2021) Quantitative assessment of lung involvement on chest CT at admission: impact on hypoxia and outcome in COVID-19 patients. Clin Imaging 77:194–201. https://doi.org/10.1016/J.CLINIMAG.2021.04.033
doi: 10.1016/J.CLINIMAG.2021.04.033
pubmed: 33984670
pmcid: 8081746
Salvatore C, Roberta F, de Angela L et al (2021) Clinical and laboratory data, radiological structured report findings and quantitative evaluation of lung involvement on baseline chest CT in COVID-19 patients to predict prognosis. Radiol Med 126:29–39. https://doi.org/10.1007/S11547-020-01293-W
doi: 10.1007/S11547-020-01293-W
pubmed: 33047295
Roberts M, Driggs D, Thorpe M, et al (2021) Common pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scans. Nature Machine Intelligence 2021 3:3 3:199–217. https://doi.org/10.1038/s42256-021-00307-0
Sabatino J, de Rosa S, di Salvo G, Indolfi C (2020) Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis. PLoS One 15. https://doi.org/10.1371/JOURNAL.PONE.0237131
Cereda A, Toselli M, Palmisano A et al (2022) Coronary calcium score as a predictor of outcomes in the hypertensive Covid-19 population: results from the Italian (S) Core-Covid-19 Registry. Hypertens Res 45:333–343. https://doi.org/10.1038/S41440-021-00798-9
doi: 10.1038/S41440-021-00798-9
pubmed: 34789917
Sticchi A, Cereda A, Toselli M et al (2021) Diabetes and mortality in patients with COVID-19: Are we missing the link? Anatol J Cardiol 25:376–379. https://doi.org/10.5152/ANATOLJCARDIOL.2021.29132
doi: 10.5152/ANATOLJCARDIOL.2021.29132
pubmed: 34100723
pmcid: 8210942
Scoccia A, Gallone G, Cereda A et al (2021) Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19. Atherosclerosis 328:136–143. https://doi.org/10.1016/J.ATHEROSCLEROSIS.2021.03.041
doi: 10.1016/J.ATHEROSCLEROSIS.2021.03.041
pubmed: 33883086
pmcid: 8025539
Conte C, Esposito A, De Lorenzo R et al (2021) Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: a post-hoc analysis of a prospective cohort study. Nutr Metab Cardiovasc Dis 31:2156–2164. https://doi.org/10.1016/J.NUMECD.2021.04.020
doi: 10.1016/J.NUMECD.2021.04.020
pubmed: 34059384
pmcid: 8091800
Giannini F, Toselli M, Palmisano A et al (2021) Coronary and total thoracic calcium scores predict mortality and provides pathophysiologic insights in COVID-19 patients. J Cardiovasc Comput Tomogr 15:421–430. https://doi.org/10.1016/J.JCCT.2021.03.003
doi: 10.1016/J.JCCT.2021.03.003
pubmed: 33744175
pmcid: 7946543
Schiaffino S, Albano D, Cozzi A et al (2021) CT-derived chest muscle metrics for outcome prediction in patients with COVID-19. Radiology 300:E328–E336. https://doi.org/10.1148/RADIOL.2021204141
doi: 10.1148/RADIOL.2021204141
pubmed: 33724065
Al-Mallah MH, Qureshi W, Lin FY et al (2014) Does coronary CT angiography improve risk stratification over coronary calcium scoring in symptomatic patients with suspected coronary artery disease? Results from the prospective multicenter international CONFIRM registry. Eur Heart J Cardiovasc Imaging 15:267–274. https://doi.org/10.1093/EHJCI/JET148
doi: 10.1093/EHJCI/JET148
pubmed: 23966421
Jacobs PC, Prokop M, van der Graaf Y et al (2010) Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers. Atherosclerosis 209:455–462. https://doi.org/10.1016/J.ATHEROSCLEROSIS.2009.09.031
doi: 10.1016/J.ATHEROSCLEROSIS.2009.09.031
pubmed: 19875116
Jang S, Graffy PM, Ziemlewicz TJ et al (2019) Opportunistic osteoporosis screening at routine abdominal and thoracic CT: normative L1 trabecular attenuation values in more than 20 000 adults. Radiology 291:360. https://doi.org/10.1148/RADIOL.2019181648
doi: 10.1148/RADIOL.2019181648
pubmed: 30912719
Correa-de-Araujo R, Addison O, Miljkovic I et al (2020) Myosteatosis in the context of skeletal muscle function deficit: an interdisciplinary workshop at the National Institute on Aging. Front Physiol 11:963. https://doi.org/10.3389/FPHYS.2020.00963/BIBTEX
doi: 10.3389/FPHYS.2020.00963/BIBTEX
pubmed: 32903666
pmcid: 7438777
Ohara DG, Pegorari MS, Oliveira dos Santos NL et al (2020) Cross-sectional study on the association between pulmonary function and sarcopenia in Brazilian community-dwelling elderly from the Amazon region. J Nutr Health Aging 24:181–187. https://doi.org/10.1007/S12603-019-1290-Y
doi: 10.1007/S12603-019-1290-Y
pubmed: 32003408
Miljkovic I, Vella CA, Allison M (2021) Computed tomography-derived myosteatosis and metabolic disorders. Diabetes Metab J 45:482–491. https://doi.org/10.4093/DMJ.2020.0277
doi: 10.4093/DMJ.2020.0277
pubmed: 34352985
pmcid: 8369205
Jawahar A, Gonzalez B, Balasubramanian N et al (2020) Comparison of computed tomography hepatic steatosis criteria for identification of abnormal liver function and clinical risk factors, in incidentally noted fatty liver. Eur J Gastroenterol Hepatol 32:216–221. https://doi.org/10.1097/MEG.0000000000001502
doi: 10.1097/MEG.0000000000001502
pubmed: 31584463
Esposito A, Palmisano A, Toselli M et al (2021) Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy. Eur Radiol 31:4031–4041. https://doi.org/10.1007/S00330-020-07622-X
doi: 10.1007/S00330-020-07622-X
pubmed: 33355697
Cereda A, Toselli M, Palmisano A et al (2021) The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification. Geroscience 43:2215–2229. https://doi.org/10.1007/S11357-021-00409-Y
doi: 10.1007/S11357-021-00409-Y
pubmed: 34260010
pmcid: 8278366
Boyce CJ, Pickhardt PJ, Kim DH et al (2010) Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol 194:623–628. https://doi.org/10.2214/AJR.09.2590
doi: 10.2214/AJR.09.2590
pubmed: 20173137
Derstine BA, Holcombe SA, Ross BE, et al (2018) Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population. Sci Rep 8. https://doi.org/10.1038/S41598-018-29825-5
Pickhardt PJ, Pooler BD, Lauder T et al (2013) Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann Intern Med 158:588–595. https://doi.org/10.7326/0003-4819-158-8-201304160-00003
doi: 10.7326/0003-4819-158-8-201304160-00003
pubmed: 23588747
pmcid: 3736840
Kodama Y, Ng CS, Wu TT et al (2007) Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 188:1307–1312. https://doi.org/10.2214/AJR.06.0992
doi: 10.2214/AJR.06.0992
pubmed: 17449775
Kirwan R, McCullough D, Butler T et al (2020) Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss. Geroscience 42:1547–1578. https://doi.org/10.1007/S11357-020-00272-3
doi: 10.1007/S11357-020-00272-3
pubmed: 33001410
pmcid: 7528158
Batta Y, King C, Johnson J, et al (2022) Sequelae and Comorbidities of COVID-19 Manifestations on the Cardiac and the Vascular Systems. Front Physiol 12. https://doi.org/10.3389/FPHYS.2021.748972
Miedema MD, Dardari ZA, Nasir K, et al (2019) Association of coronary artery calcium with long-term, cause-specific mortality among young adults. JAMA Netw Open 2. https://doi.org/10.1001/JAMANETWORKOPEN.2019.7440
Palmisano A, Vignale D, Boccia E et al (2022) AI-SCoRE (artificial intelligence-SARS CoV2 risk evaluation): a fast, objective and fully automated platform to predict the outcome in COVID-19 patients. Radiol Med. https://doi.org/10.1007/S11547-022-01518-0
doi: 10.1007/S11547-022-01518-0
pubmed: 36038790
pmcid: 9423702
Lee KK, Rahimi O, Lee CK et al (2022) A meta-analysis: coronary artery calcium score and COVID-19 prognosis. Med Sci (Basel) 10:5. https://doi.org/10.3390/MEDSCI10010005
doi: 10.3390/MEDSCI10010005
pubmed: 35225939
Zeb I, Li D, Nasir K, et al (2012) Computed tomography scans in the evaluation of fatty liver disease in a population based study. The Multi-Ethnic Study of Atherosclerosis. Acad Radiol 19. https://doi.org/10.1016/j.acra.2012.02.022
Park SH, Kim PN, Kim KW et al (2006) Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 239:105–112. https://doi.org/10.1148/RADIOL.2391050361
doi: 10.1148/RADIOL.2391050361
pubmed: 16484355
Narayanan S, Surette FA, Hahn YS (2016) The immune landscape in nonalcoholic steatohepatitis. Immune Netw 16:147–158. https://doi.org/10.4110/IN.2016.16.3.147
doi: 10.4110/IN.2016.16.3.147
pubmed: 27340383
pmcid: 4917398
Chen N, Zhou M, Dong X et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507–513. https://doi.org/10.1016/S0140-6736(20)30211-7
doi: 10.1016/S0140-6736(20)30211-7
pubmed: 32007143
pmcid: 7135076
Bramante CT, Tignanelli CJ, Dutta N, et al (2020) Non-alcoholic fatty liver disease (NAFLD) and risk of hospitalization for Covid-19. medRxiv 2020.09.01.20185850. https://doi.org/10.1101/2020.09.01.20185850
Nava-Santana C, Rodríguez-Armida M, Jiménez JV, et al (2022) Clinicopathologic characteristics of severe COVID-19 patients in Mexico City: a post-mortem analysis using a minimally invasive autopsy approach. PLoS One 17:e0262783. https://doi.org/10.1371/JOURNAL.PONE.0262783
Ekiz T, Kara M, Özcan F et al (2020) Sarcopenia and COVID-19: a manifold insight on hypertension and the renin angiotensin system. Am J Phys Med Rehabil 99:880–882. https://doi.org/10.1097/PHM.0000000000001528
doi: 10.1097/PHM.0000000000001528
pubmed: 32657817
Nardo AD, Schneeweiss-Gleixner M, Bakail M et al (2021) Pathophysiological mechanisms of liver injury in COVID-19. Liver Int 41:20–32. https://doi.org/10.1111/LIV.14730
doi: 10.1111/LIV.14730
pubmed: 33190346
Sachdeva S, Khandait H, Kopel J et al (2020) NAFLD and COVID-19: a pooled analysis. SN Compr Clin Med 2:2726–2729. https://doi.org/10.1007/S42399-020-00631-3
doi: 10.1007/S42399-020-00631-3
pubmed: 33173850
pmcid: 7646222
Milic J, Barbieri S, Gozzi L, et al (2022) Metabolic-associated fatty liver disease is highly prevalent in the postacute COVID syndrome. Open Forum Infect Dis 9. https://doi.org/10.1093/OFID/OFAC003
Meyer HJ, Wienke A, Surov A (2022) Computed tomography-defined body composition as prognostic markers for unfavourable outcomes and in-hospital mortality in coronavirus disease 2019. J Cachexia Sarcopenia Muscle 13:159–168. https://doi.org/10.1002/JCSM.12868
doi: 10.1002/JCSM.12868
pubmed: 35018725
pmcid: 8818651
Elliott JE, Greising SM, Mantilla CB, Sieck GC (2016) Functional impact of sarcopenia in respiratory muscles. Respir Physiol Neurobiol 226:137–146. https://doi.org/10.1016/J.RESP.2015.10.001
doi: 10.1016/J.RESP.2015.10.001
pubmed: 26467183
van Gassel RJJ, Bels J, Remij L et al (2021) Functional outcomes and their association with physical performance in mechanically ventilated coronavirus disease 2019 survivors at 3 months following hospital discharge: a cohort study. Crit Care Med 49:1726–1738. https://doi.org/10.1097/CCM.0000000000005089
doi: 10.1097/CCM.0000000000005089
pubmed: 33967204
pmcid: 8439632
de Lorenzo R, Palmisano A, Esposito A, et al (1AD) Myosteatosis significantly predicts persistent dyspnea and mobility problems in COVID-19 survivors. Front Nutr 0:599. https://doi.org/10.3389/FNUT.2022.846901
Cossu A, Palumbo D, Battaglia S et al (2023) Sarcopenia and patient’s body composition: new morphometric tools to predict clinical outcome after Ivor Lewis esophagectomy: a Multicenter Study. J Gastrointest Surg. https://doi.org/10.1007/S11605-023-05611-1
doi: 10.1007/S11605-023-05611-1
pubmed: 36750544
Pickhardt PJ, Graffy PM, Perez AA et al (2021) Opportunistic screening at abdominal CT: use of automated body composition biomarkers for added cardiometabolic value. Radiographics 41:524–542. https://doi.org/10.1148/RG.2021200056
doi: 10.1148/RG.2021200056
pubmed: 33646902
Modanwal G, Al-Kindi S, Walker J, et al (2022) Deep-learning-based hepatic fat assessment (DeHFt) on non-contrast chest CT and its association with disease severity in COVID-19 infections: A multi-site retrospective study. EBioMedicine 85. https://doi.org/10.1016/J.EBIOM.2022.104315